Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Drug Discovery & Development

    Hongene to supply exNA oligonucleotide technology under new licensing deal

    Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Adva Biotechnology and Autolomous launch digital pioneer program for scalable autologous cell therapy manufacturing

    Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Biostate AI launches K-Dense beta to accelerate biological discovery from years to days

    Biostate AI has launched K-Dense Beta, a multi-agent AI system [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    SynGenSys launches NK.SET synthetic promoter library to support NK cell therapy development

    SynGenSys, a biotechnology company developing synthetic gene promoter systems, has [...]

    May 5, 2026
  • Drug Discovery & Development,Genomics and sequencing

    Bio-Rad expands range of StarBright dyes to enhance panel design capabilities for spectral flow cytometry

    Bio-Rad Laboratories, a global provider of life science research and [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Strand Therapeutics appoints Jason Luke as chief medical officer

    Strand Therapeutics has appointed oncology researcher Jason Luke as its [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    A potential first-in-class treatment for children with achondroplasia is now in clinical testing

    Tyra Biosciences has dosed the first child in BEACH301, its [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    May 5, 2026
Previous555657Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Norstella launches agentic AI platform for biopharma decision-making
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
  • AI model cuts radiopharmaceutical dose mapping to seconds in prostate cancer study
    Categories: Digital & Data, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Piramal Pharma Solutions expands peptide API facility with spray drying suite
    Categories: Drug Delivery & Formulation, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top